Prentað þann 31. okt. 2024
233/2001
Reglugerð um ávana- og fíkniefni og önnur eftirlitsskyld efni.
I. KAFLI Almenn ákvæði.
1. gr. Ávana- og fíkniefni.
Með ávana- og fíkniefnum og öðrum eftirlitsskyldum efnum er átt við:
- Efni, sem skráð eru á listum I - IV í alþjóðasamningi um ávana- og fíkniefni 1961 með síðari breytingum, (Single Convention on Narcotic Drugs 1961), merkt N I – N IV í fylgiskjali I með þessari reglugerð.
- Efni, sem skráð eru á listum I - IV í alþjóðasamningi um ávana- og fíkniefni 1971 ásamt viðaukum, (Convention on Psychotropic Substances 1971), merkt P I – P IV í fylgiskjali I með þessari reglugerð.
- Efni, sem nota má við ólöglega ræktun, framleiðslu eða tilbúning ávana- og fíkniefna og annarra eftirlitsskyldra efna og skráð eru í listum I - II í alþjóðasamningi gegn ólöglegri verslun með ávana- og fíkniefni 1988, (United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988), merkt D I – D II í fylgiskjali II með þessari reglugerð.
Ennfremur sölt, esta, amíð, peptíð og hvers konar afleiður (afbrigði) efnanna sem tilgreind eru í fylgiskjölum I og II, þar með taldar afleiður, sem eru frábrugðnar upprunalega efninu (viðmiðunarefninu) að því er varðar staðsetningu efnahóps eða efnahópa á kolefni, köfnunarefni, súrefni og/eða brennisteini.
Einnig er átt við lyfjaform áðurgreindra efnasambanda (t.d. töflur, hylki, stungulyf) svo og önnur lyf og efni sem misnota má á svipaðan hátt og hafa skaðleg áhrif á heilsu manna.
Hugtakið ávana- og fíkniefni tekur einnig til ávana- og fíknilyfja.
Ávana- og fíknilyf eru þau lyf, sem ætla má að geti haft skaðleg áhrif vegna fíkni- eða ávanahættu, enda geti þau vegna eiginleika sinna valdið því að notandi þeirra verði háður þeim vegna vanabindingar eða líkamlegrar fíknar.
2. gr.
Innflutningur, útflutningur, sala, kaup, skipti, afhending, móttaka, framleiðsla, tilbúningur og varsla ávana- og fíkniefna, sem merkt eru með "x" í dálki B í fylgiskjali I með reglugerð þessari er óheimil á íslensku forráðasvæði.
Lyfjastofnun getur veitt undanþágu frá þessu banni vegna vísindalegra rannsókna eða af öðrum sérstökum ástæðum. Nú er reglum eða skilyrðum, sem Lyfjastofnun setur um slíkar undanþágur ekki fullnægt og er Lyfjastofnun þá heimilt að nema þegar í stað úr gildi eða takmarka slíkar undanþágur.
II. KAFLI Eftirritunarskylda og förgun.
3. gr. Eftirritunarskylda.
Ávana- og fíknilyf eru eftirritunarskyld, ef þau vegna eiginleika sinna geta haft í för með sér sérstaka hættu á misnotkun.
Lyf, sem innihalda efni sem merkt eru N I - N IV og P I - P III í fylgiskjali I eru eftirritunarskyld.
Lyfjastofnun er heimilt að höfðu samráði við landlækni, að bæta við eða undanskilja eftirritunarskyldu ákveðin lyf, lyfjaform eða styrkleika. Um eftirritunarskyld lyf gilda sérstakar reglur um ávísun þeirra, afgreiðslu, móttöku og skráningu upplýsinga, sbr. reglugerð um lyfjaávísanir og afhendingu lyfja, með síðari breytingum.
4. gr.
Við veitingu markaðsleyfis vegna lyfs, sem fellur undir ákvæði 3. gr., skal Lyfjastofnun kveða á um eftirritunarskyldu. Þegar um er að ræða lyf í ATC-flokkum N 05 B A og N 05 C skal takmarka það magn, sem afgreiða má hverju sinni og miða við ákvæði 10. gr. þessarar reglugerðar.
Lyfjastofnun skal á aðgengilegan hátt birta upplýsingar um eftirritunarskyldu lyfs við veitingu markaðsleyfis.
5. gr. Förgun eftirritunarskyldra lyfja og efna.
Fyrnd eða ónýt eftirritunarskyld lyf úr birgðum lyfjabúða skulu send Lyfjastofnun til förgunar með ábyrgðarpósti eða afhent starfsmanni stofnunarinnar. Í fylgibréfi skal tilgreina hvaða lyf er um að ræða og í hvað magni, auk þess sem fram skal koma dagsetning og hver sendandinn er. Lyfjastofnun skal staðfesta skriflega móttöku eftirritunarskyldra lyfja til förgunar.
Þrátt fyrir ákvæði 1. mgr. er heimilt að skila fyrndum eftirritunarskyldum lyfjum til lyfjaheildsölu, ef unnt er að fá þau endurgreidd að hluta eða fullu. Staðfestingu lyfjaheildsölu á móttöku lyfjanna skal varðveita í lyfjabúð í að minnsta kosti 2 ár.
Lyfjastofnun getur heimilað, að eftirritunarskyldum lyfjum sé fargað á vegum lyfjabúðar. Slík heimild skal vera skrifleg og setja má skilyrði um framkvæmd og annað er stofnunin telur nauðsynlegt. Eftirritunarskyld lyf, sem skilað er til lyfjabúðar, skal senda með tryggilegum hætti til förgunar með öðrum lyfjum.
Óheimilt er að farga ávana- og fíkniefnum nema í samráði við Lyfjastofnun og að viðstöddum starfsmanni stofnunarinnar.
Aðilar, sem annast vörslu og meðferð efna skv. reglugerð þessari skulu gera ársskýrslur varðandi umrædd efni á sérstöku eyðublaði, sem látið er í té af Lyfjastofnun. Ennfremur skulu þeir gefa á hverjum tíma þær skýrslur og upplýsingar, sem Lyfjastofnun telur nauðsynlegar til eftirlits.
III. KAFLI Inn- og útflutningur.
6. gr. Inn- og útflutningur ávana- og fíkniefna.
Efni, sem merkt eru N I - N IV, P I - P IV og D I í fylgiskjölum með reglugerð þessari er aðeins heimilt að flytja inn eða út, framleiða og selja í heildsölu að fengnu leyfi Lyfjastofnunar.
Þeir sem hyggjast flytja inn efni samkvæmt 1. mgr., hvort sem er í formi hráefnis eða lyfjaforma, skulu sækja um innflutningsleyfi til Lyfjastofnunar í hvert sinn, áður en pöntun er gerð. Í umsókn skal greina:
- Nafn og heimilisfang umsækjanda.
- Nafn og heimilisfang seljanda/kaupanda.
- Heiti og magn efnis, sem um er að ræða (INN nafn).
- Til hvers á að nota efnið.
7. gr. Inn- og útflutningur efna, sem nota má við ólöglega ræktun, framleiðslu eða tilbúning ávana- og fíkniefna og annarra eftirlitsskyldra efna.
Efni, sem merkt eru D II í fylgiskjali II er aðeins heimilt að flytja inn eða út, framleiða og selja í heildsölu að fengnu leyfi Lyfjastofnunar og skal leyfið bundið hverju einstöku efni. Aðilar, sem annast vörslu og meðferð þessara efna skulu fylgja ákvæðum um skráningu á afhendingu eftirlitsskyldra efna skv. nánari leiðbeiningum þar að lútandi. Innflytjandi skal hafa leyfi Lyfjastofnunar til innflutnings og framvísa tollyfirvöldum sé þess krafist.
Þeir sem hyggjast flytja inn efni samkvæmt 1. mgr., hvort sem er í formi hráefnis eða lyfjaforma, skulu sækja um innflutningsleyfi til Lyfjastofnunar í hvert sinn, áður en pöntun er gerð, þegar um er að ræða efni, sem merkt eru D I og efni, sem merkt eru D II, ef magn er meira en það hámark, sem tilgreint er í fylgiskjali II. Í umsókn skal greina sömu atriði og kveðið er á um í 2. mgr. 6. gr.
Leyfishöfum er einum heimilt að afhenda umrædd efni öðrum aðila, sem hefur leyfi Lyfjastofnunar til vörslu, meðferðar eða sölu þeirra. Þetta ákvæði nær ekki til afhendingar lyfjabúða og annarra, er leyfi hafa til lyfjasölu.
8. gr.
Það er skilyrði fyrir tollafgreiðslu efna, sem 7. gr. tekur til, að í bókhaldi viðkomandi inn- eða útflytjanda liggi fyrir leyfi Lyfjastofnunar. Í sendingum skulu koma fram upplýsingar um heiti efna sem skulu vera í samræmi við inn- eða útflutningsleyfi hverju sinni, en slík áritun skal ekki vera á ytri umbúðum sendinga. Jafnskjótt og innflytjandi hefur veitt efninu viðtöku, skal hann rita dagsetningu, heiti og magn efnisins sem hann veitti viðtöku á afrit sitt af innflutningsleyfinu og senda afritið til Lyfjastofnunar.
9. gr.
Innflutningsleyfið gildir að jafnaði í fjóra mánuði nema Lyfjastofnun heimili annað. Sé útgefið leyfi ekki notað skal tilkynna það Lyfjastofnun skriflega í síðasta lagi þann dag, er leyfið rennur út. Ef um óunnið eða hálfunnið hráefni er að ræða, skal flytja inn heimilað magn í einu lagi.
Sömu ákvæði og að framan greinir um innflutning gilda einnig, ef um útflutning er að ræða.
Ákvæði þessi um innflutning og útflutning eiga ekki við um þau ávana- og fíknilyf, sem samkv. gildandi reglum skulu vera í lyfjakistum skipa eða loftfara og ekki heldur um þau lyf, sem einstaklingar með búsetu í landi, sem á aðild að Schengen-samningnum, flytja með sér til eigin nota og ávísað hefur verið á lögmætan hátt til allt að 30 daga notkunar, ef fyrirmælum læknis er hlítt, sbr. ákvæði 75. gr. Schengen-samningsins og reglugerð um innflutning einstaklinga á lyfjum til eigin nota. Á sama hátt er einstaklingum með búsetu utan Schengen heimilt að flytja með sér lyf til eigin nota og ávísað hefur verið á lögmætan hátt til allt að 14 daga notkunar, ef fyrirmælum læknis er hlítt, sbr ákvæði reglugerðar um innflutning einstaklinga á lyfjum til eigin nota.
IV. KAFLI Lyf, sem afgreiða má í takmörkuðu magni.
10. gr.
Lyf í ATC-flokkum N 05 B A og N 05 C, sem eru merkt P IV í fylgiskjali I má einungis afgreiða í magni, sem svarar til 30 daga notkunar og skal að öllu jöfnu miðað við skilgreindan dagskammt (Defined Daily Dose (DDD)).
Við veitingu markaðsleyfis ofangreindra lyfja skal Lyfjastofnun ákveða það magn, sem leyfilegt er að afgreiða hverju sinni og taka tillit til þeirra pakkninga, sem veitt er markaðsleyfi fyrir. Að jafnaði skal miðað við, að fremur sé heimilað minna magn en meira.
Lyfjastofnun getur í samráði við landlækni, heimilað að ákveðin lyf, lyfjaform eða styrkleika megi afgreiða í meira magni, en svarar til 30 daga notkunar.
Upplýsingar um það magn, sem leyfilegt er að afgreiða skulu birtar í sérlyfjaskrá, en Lyfjastofnun skal á aðgengilegan hátt birta upplýsingar um leyfilegt hámarksmagn á lyfseðli við veitingu markaðsleyfis.
Víkja má frá ákvæðum 1. og 2. mgr., ef læknir óskar eftir því á lyfseðli að þessi lyf verði skömmtuð í sérstakar skammtaöskjur, ásamt öðrum lyfseðilsskyldum lyfjum, sbr. ákvæði reglugerðar um gerð lyfseðla og ávísun lyfja nr. 111/2001.
11. gr.
Hafi skilgreindur dagskammtur lyfs, sem fellur undir 10. gr., ekki verið ákveðinn, skal Lyfjastofnun við veitingu markaðsleyfis ákveða leyfilegt magn, sem heimilað er að afgreiða hverju sinni.
Telji Lyfjastofnun að lyf, sem ekki fellur undir 10. gr. geti haft ávana- eða fíknihættu í för með sér, skal stofnunin ákveða það magn, sem leyfilegt er að afgreiða hverju sinni og taka mið af almennum ákvæðum í 10. gr.
12. gr.
Þegar Lyfjastofnun veitir heimild til notkunar lyfs er ekki hefur markaðsleyfi hér á landi, skal stofnunin ákvarða eftirritunarskyldu og takmörkun á afgreiddu magni í samræmi við ákvæði þessarar reglugerðar.
V. KAFLI Eftirlit, viðurlög og gildistaka
13. gr.
Sérstakt eftirlit er haft með ávísunum á eftirritunarskyld ávana- og fíknilyf, sbr. 3. gr. Lyfjastofnun tilkynnir landlækni leiki grunur á óeðlilegum lyfjaávísunum lækna eða tannlækna á ávana- og fíknilyf, en yfirdýralækni leiki grunur á óeðlilegum lyfjaávísunum dýralækna á ávana- og fíknilyf.
Lyfjastofnun hefur eftirlit með að farið sé að ákvæðum reglugerðar þessarar. Skylt er að láta Lyfjastofnun í té þau gögn eða upplýsingar sem stofnunin telur nauðsynleg vegna eftirlitsins, sbr. 42. gr. lyfjalaga með síðari breytingum.
14. gr.
Brot gegn reglugerð þessari varða sektum eða fangelsi allt að 6 árum, nema þyngri refsing liggi við skv. lögum. Tilraun og hlutdeild í brotum gegn reglugerð þessari eru refsiverð samkvæmt III. kafla almennra hegningarlaga.
Ávana- og fíkniefni og önnur eftirlitsskyld efni, sem aflað hefur verið á ólögmætan hátt eða eru á annan hátt í ólögmætri vörslu, skal gera upptæk til ríkissjóðs. Þá skal og heimilt að gera upptækt til ríkissjóðs andvirði ólögmætrar sölu ávana- og fíkniefna svo og hvers konar muni og áhöld, sem notuð hafa verið eða ætluð eru til ólögmætrar meðferðar efnanna.
15. gr.
Reglugerð þessi, sem sett er með heimild í 12. gr. lyfjalaga nr. 93/1994 með síðari breytingum og 2. gr. laga um ávana- og fíkniefni nr. 65 frá 21. maí 1974 með síðari breytingum öðlast gildi 1. apríl 2001. Jafnframt falla þá úr gildi 15. – 21. gr. og 43. gr. reglugerðar nr. 421/1988 um gerð lyfseðla og ávísun lyfja, afgreiðslu þeirra og merkingu. Einnig er úr gildi felld reglugerð um sölu og meðferð ávana- og fíkniefna nr. 16/1986 með síðari breytingum svo og auglýsing nr. 84/1986 um takmarkanir á ávísun lækna á amfetamín og nokkur fleiri lyf.
Skýringar
B Efni sem bönnuð eru á íslensku yfirráðasvæði, sbr. 2. gr. laga um ávana- og fíkniefni, nr. 65/1974, með síðari breytingum, og 2. gr. þessarar reglugerðar um ávana- og fíkniefni og önnur eftirlitsskyld efni, nr. 233/2001.
N I–IV Efni listuð á fylgiskjölum I–IV með alþjóðasamningi um ávana- og fíkniefni frá 1961 með síðari breytingum (Single Convention on Narcotic Drugs of 1961, and the Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs of 1961).
P I–IV Efni listuð á fylgiskjölum I–IV með alþjóðasamningi um ávana- og fíkniefni 1971 með síðari breytingum (Convention on Psychotropic Substances 1971).
Efni | Annað nafn | IUPAC (Alþjóðasamtök um hreina og hagnýta efnafræði) | Alþjóða- samningar | B | Undanþágur og athugasemdir |
1cP-LSD | 1-cyclopropanoyl-LSD | x | |||
(1-phenyl-1-piperidyl-(2)methyl)acetate | (1-phenyl-1-piperidyl-(2)-methyl)acetate | x | |||
1,3-benzodioxolylbutanamine | BDB | 1-(1,3-benzodioxol-5-yl)butan-2-amine | x | ||
1,3-Benzodioxolyl-Nmethylbutanamine | MBDB | 1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine | x | ||
1,4-butanediol | BD | butane-1,4-diol | x | 5) | |
1-phenethylamine | 1-PEA | 1-phenylethan-1-amine | x | ||
1P-LSD | 1-propionyllysergid | N,N-diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide | x | ||
2,3-DMMC | 2,3-dimethylmethcathinone | x | |||
2,4-DMMC | 2,4-dimethylmethcathinone | x | |||
2,4-DMPPP | 1-(2,4-dimethylphenyl)-2-pyrrolidine-1-yl-propan-1-one | x | |||
2,5-dimethoxy-4bromoamphetamine | DOBBrolamfetamineBromo-DMA | 1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine | P I | x | |
2,5-dimethoxy-4ethylamphetamine | DOET | 1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine | P I | x | |
2,5-dimethoxy-4-fluoroamphetamine | 1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine | x | |||
2,5-dimethoxy-4methylamphetamine | DOMSTP | 1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine | P I | x | |
2,5-dimethoxy-4-nitroamphetamine | 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine | x | |||
25B-NBF | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25B-NBOH | 2-([2-(4-bromo-2,5-dimethoxyphenyl)ethylamino]methyl)phenol | x | |||
25B-NBOMe | NBOMe-2C-BCimbi-36 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine | P I | x | |
25C-NBF | 2-(4-chloro-2,5-dimethoxiphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25C-NBOMe | NBOMe-2C-C Cimbi-82 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine | P I | x | |
25D-NBOMe | NBOMe-2C-D | 2-(2,5-dimethoxy-4-methylphenyl)-N-[(2methoxyphenyl)methyl]ethanamine | x | ||
25E-NBOH | 2-[([2-(4-ethyl-2,5-dimethoxiphenyl)ethyl]amino)methyl]phenol | x | |||
25E-NBOMe | 2-(4-ethyl-2,5-dimethoxiphenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
25G-NBOMe | 2-(2,5-dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
25H-NBOMe | 2-(2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine | x | |||
25I-NB34MD | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(3,4-methylenedioxyphenyl)methyl]ethanamine | x | |||
25I-NBF | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25I-NBMD | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2,3-methylenedioxyphenyl)methyl]ethanamine | x | |||
25I-NBOH | 2-([2-(4-iodo-2,5-dimethoxyphenyl)ethylamino]methyl)phenol | x | |||
25I-NBOMe | NBOMe-2C-I Cimbi-5 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine | P I | x | |
25N-NBOMe | 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
2-aminoindane | 2-Al | 2,3-dihydro-1H-inden-2-amine | x | ||
2C-B | 2,5-dimethoxy-4-bromophenethylamine | 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine | P II | x | |
2C-B-FLY | 2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)ethanamine | x | |||
2C-C | 2,5-dimethoxy-4-methyl-betaphenethylamine | 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine | x | ||
2C-D | 2,5-dimethoxy-4-methylphenethylamine | 2-(2,5-dimethoxy-4-methylphenyl)ethanamine | x | ||
2C-E | 2,5-dimethoxy-4-ethylphenethylamine | 2-(4-ethyl-2,5-dimethoxyphenyl)ethanamine | x | ||
2C-F* | 2,5-dimethoxy-4-fluorophenethylamine | x | |||
2C-H | 2,5-dimethoxyphenethylamine | x | |||
2C-I | 2,5-dimethoxy-4-iodophenethylamine | 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine | x | ||
2-Cl-4,5-MDMA | 2-chloro-4,5-methylenedioxymethamphetamine | x | |||
2-CMC | 2-Chloromethcathinone | 1-(2-chlorophenyl)-2-(methylamino)-1-propanone | x | ||
2C-P | 2,5-dimethoxy-4-propylphenethylamine | 2-(2,5-dimethoxy-4-propylphenyl)ethanamine | x | ||
2C-T-2 | 2,5-dimethoxy-4-ethylthiophenethylamine | 2-(4-ethylthio-2,5-dimethoxyphenyl)ethanamine | x | ||
2C-T-4 | 2,5-dimethoxy-4- isopropylthiophenethylamine | 2-(2,5-dimethoxy-4-[(1-methylethyl)thio]phenyl)ethanamine | x | ||
2C-T-7 | 2,5-dimethoxy-4-propylthiophenethylamine | 2-(2,5-dimethoxy-4-propylthio-phenyl)ethanamine | x | ||
2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | 2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | x | |||
2-(ethylamino)propiophenone | 2-(ethylamino)-1-phenylpropan-1-one | x | |||
2-fluoroamphetamine | 2-FA | 1-(2-fluorophenyl)propan-2-amine | x | ||
2-fluoromethamphetamine | 2-FMA | 1-(2-fluorophenyl)-N-methylpropan-2-amine | x | ||
2-fluoromethcathinone | 2-FMC | 1-(2-fluorophenyl)-2-(methylamino)propan-1-one | x | ||
2-MEC | 2-methyl-N-ethylcathinone | x | |||
2-methylacetylfentanyl | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-methylphenyl)acetamide | x | |||
2-methylamphetamine | 2-MA | 1-(2-methylphenyl)propan-2-amine | x | ||
2-(methylamino)hexanophenone | 2-methylamino-1-phenylhexan-1-one | x | |||
2-methyl-AP-237 | 1-[4-(3-phenylprop-2-en-1-yl)-2-methylpiperazin-1-yl]butan-1-one | x | |||
2-methylmethcathinone | 2-MMC | 2-(methylamino)-1-(2-methylphenyl)propan-1-one | x | ||
3-(4-hydroxymethylbenzoyl)-1pentylindole | [4-(hydroxymethyl)phenyl](1-pentyl-1H-indol-3yl)methanone | x | |||
3,4,5-trimethoxybenzaldehyde | 3,4,5-trimethoxybenzaldehyde | x | |||
3,4-DCEC | 3,4-dichloroethcathinone | x | |||
3,4-Dichloro-N,N-cyclohexylmethylmethcathinone | 2-(cyclohexyl(methyl)amino)-1-(3,4-dichlorophenyl)propan-1-one | x | |||
3,4-dichloromethylphenidate | methyl-2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate | x | |||
3,4-Dimethoxy-α-PHP | 1-(3,4-dimethoxyphenyl)-2-pyrrolidin-1-ylhexan-1-one | x | |||
3,4-dimethylmethcathinone | 3,4-DMMC | 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | x | ||
3,4-DMA | 3,4-dimethoxyamphetamine | x | |||
3,4- methylenedioxyethamphetamine | MDEA MDE N-ethyl-MDA | 1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine | P I | x | |
3,4-methylenedioxy-Nhydroxyamphetamine | N-hydroxy-MDA | N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]hydroxylamine | P I | x | |
3',4'-methylenedioxy-αpyrrolidinopropiophenone | MDPPP | 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylpropan-1-one | x | ||
3,4-methylenedioxy-U-47700 | N-[2-(dimethylamino)cyclohexyl]-N-methyl-2H-1,3-benzodioxol-5-carboxamide | x | |||
3-bromomethcathinone | 3-BMC | 1-(3-bromophenyl)-2-(methylamino)propan-1-one | x | ||
3-chloroethcathinone | 3-CEC | 2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | x | ||
3-chloromethcathinone | 3-CMC | 1-(3-chlorophenyl)-2-(methylamino)-1-propanone | x | ||
3-Desoxy-MDPV | 5-DMFPV | 5-dihydrobenzofuranpyrovalerone | x | ||
3-fluoroamphetamine | 3-FA | 1-(3-fluorophenyl)propan-2-amine | x | ||
3-fluoroethylamphetamine | 3-FEA | N-ethyl-1-(3-fluorophenyl)propan-2-amine | x | ||
3-fluoromethamphetamine | 3-FMA | 1-(3-fluorophenyl)-N-methylpropan-2-amine | x | ||
3-fluoromethcathinone | 3-FMC | 1-(3-fluorophenyl)-2-(methylamino)propan-1-one | x | ||
3-fluorophenmetrazine | 3-FPM | 2-(3-fluorophenyl)-3-methylmorpholine | x | ||
3-hydroxyphenazepam | 7-bromo-3-hydroxy-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
3-hydroxyphencyclidine | 3-HO-PCP | 3-[1-(piperidin-1-yl)cyclohexyl]phenol | x | ||
3-methoxyeticyclidine | 3-MeO-PCE | N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine | x | ||
3-methoxymethcathinone | 3-MeOMC | 1-(3-methoxyphenyl)-2-(methylamino)propan-1-one | x | ||
3-methylamphetamine | 3-MA | 1-(3-methylphenyl)propan-2-amine | x | ||
3-methylcrotonylfentanyl | 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | x | |||
3-methylethcathinone | 3-MEC | 2-(ethylamino)-1-(3-methylphenyl)propan-1-one | x | ||
3-methylfentanyl | Mefentanyl 3-MF | N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-Nphenylpropanamide | N I+IV | ||
3-methylflephedrone | 1-(3-fluorophenyl)-2-(methylamino)propan-1-one | x | |||
3-methylmethcathinone | 3-MMC | 2-(methylamino)-1-(3-methylphenyl)propan-1-one | x | ||
3-methylthiofentanyl | N-[3-methyl-1-(2-thien-2-ylethyl)piperidin-4-yl]-Nphenylpropanamide | N I+IV | |||
3-monoacetylmorphine | 3-MAM | 3-acetyl-6-hydroxy-7,8-didehydro-4,5-epoxy-17methylmorphinan | x | ||
3-phenylpropanoylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-3-phenylpropanamide | x | |||
3β-(p-fluorobenzoyloxy)tropane | p-FBT | (8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate | x | ||
4,4'-dimethylaminorex | 4,4'-DMAR | 2-amino-4-methyl-5-(4-methylphenyl)-2-oxazoline | P II | ||
4’-chloro-α- pyrrolidinopropiophenone | 4-chloro-α-PPP | 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)-1-propanone | x | ||
4’-fluoro-α- pyrrolidinooctanphenone | 4-fluoro-PV-9 4-fluoro-α-POP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)butan-1-one | x | ||
4-Acetoxy-DET | Ethacetin Ethylacybin 4-Acetoxy-N,N-diethyltryptamine | 3-[2-(diethylamino)ethyl]-1H-indol-4-yl acetate | x | ||
4-Acetoxy-DiPT | Ipracetin 4-acetoxy-N,N-diisopropyltryptamine | 3-[2-[di(propan-2-yl)amino]ethyl]-1H-indol-4-yl acetate | x | ||
4-Acetoxy-DMT | O-acetylpsilocin Psilacetin 4-acetoxy-N,N-dimethyltryptamine | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl acetate | x | ||
4-Acetoxy-MiPT | Mipracetin 4-acetoxy-N-methyl-N-isopropyltryptamine | 3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-yl acetate | x | ||
4-AcO-DMT | 4-acetoxy-N,N-dimethyltryptamine | x | |||
4-AcO-MET | 4-acetoxy-N-methyl-N-ethyltryptamine | x | |||
4-anilinopiperidine | 4-AP | N-phenyl-4-piperidinamine | x | ||
4-BMC | 4-bromomethcathinone | x | |||
4Br-α-PPP | 4-bromo-α-pyrrolidinopropiophenone | x | |||
4Br-α-PVP | 4-bromo-α-pyrrolidinovalerophenone | x | |||
4-CA | 4-chloroamphetamine | x | |||
4-CBC | 4-chloro-N-butylcathinone | x | |||
4-CEC | 4-chloroethcathinone | x | |||
4-chloro-2,5dimethoxyamphetamine | DOC 2,5-dimethoxy-4-chloroamphetamine | 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine | x | ||
4-chloro-isobutyrfentanyl | Para-chloroisobutyrfentanyl | N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide | x | ||
4-chloropentedrone | 4-chloro-α-methylaminovalerophenone | x | |||
4-chloromethcathinone | 4-CMC | 1-(4-chlorophenyl)-2-(methylamino)propan-1-one | x | ||
4-CIC | 4-chloroisopropylcathinone | x | |||
4-CMA | 4-chloromethamphetamine | x | |||
4-EMC | 1-(4-ethylphenyl)-2-(methylamino)propan-1-one | x | |||
4-FEC | 4-fluoroethcathinone | x | |||
4-Fluoroethylamphetamine | 4-FEA | N-ethyl-4-fluoro-α-methyl-benzeneethanamine | x | ||
4-fluoroamphetamine | 4-FA Para-fluoroamphetamine PFA | 1-(4-fluorophenyl)propan-2-amine | P II | ||
4-fluoromethamphetamine | 4-FMA | 1-(4-fluorophenyl)-N-methylpropan-2-amine | x | ||
4-fluoropentedrone | 4-FPD | 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one | x | ||
4'-Fluoro-α-pyrrolidinopentiophenone | 4-fluoro-α-PVP, 4F-alfa-PVP | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone | x | ||
4-HO-DET | Ethocin CZ-74 4-hydroxy-diethyl-tryptamine | 3-[2-(diethylamino)ethyl]-1H-indol-4-ol | x | ||
4-HO-DiPT | Iprocin 4-Hydroxy-di-isopropyl-tryptamine | 3-[2-[di(propan-2-yl)amino]ethyl]-1H-indol-4-ol | x | ||
4-HO-MET | Metocin Methylcybin 4-hydroxy-N-methyl-N-ethyltryptamine | 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol | x | ||
4-HO-MiPT | Miprocin 4-hydroxy-N-methyl-N-isopropyltryptamine | 3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-ol | x | ||
4-Hydroxymethcathinone | 1-(4-hydroxyphenyl)-2-(methylamino)propan-1-one | x | |||
4-iodo-2,5- dimethoxyphenylisopropylamine | DOI 2,5-dimethoxy-4-iodoamphetamine | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine | x | ||
4-MeOPBP* | 4'-methoxy-α-pyrrolidinobutiophenone | x | |||
4-MeO-PCP | 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine | x | |||
4-MeO-α-PVP | 4-methoxy-α-pyrrolidinovalerophenone | x | |||
4-methoxyamphetamine | PMA Para-methoxyamphetamine | 1-(4-methoxyphenyl)propan-2-amine | P I | x | |
4-methoxybutyrfentanyl | 4-MeO-BF | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-methoxyphenyl)butanamide | x | ||
4-methoxymethamphetamine | PMMA Para-methoxymethamphetamine | 1-(4-methoxyphenyl)-N-methylpropan-2-amine | x | ||
4-methylaminorex | 4-MAX | 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine | P I | x | |
4-methylamphetamine | 4-MA | 1-(4-methylphenyl)propan-2-amine | x | ||
4-methylbuphedrone | 4-Me-MABP | 2-(methylamino)-1-(4-methylphenyl)butan-1-one | x | ||
4-methylethcathinone | 4-MEC | 2-ethylamino-1-(4-methylphenyl)propan-1-one | P II | ||
4-methylmethamphetamine | 4-MMA | N-methyl-1-(4-methylphenyl)propan-2-amine | x | ||
4-methylthioamphetamine | 4-MTA | 1-(4-(methylthio)phenyl)propan-2-amine | P I | x | |
4-methylmethylphenidate | methyl-2-(4-methylphenyl)-2-(piperidin-2-yl)acetate | x | |||
4-methyl-α-ethylaminopentiophenone | 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone | x | |||
4-methyl-α-PiHP | 4-methyl-α-pyrrolidinoisohexanophenone | 4-methyl-1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
4F-MDMB-BINACA | methyl-2-[1-(4-fluorobutyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
4F-NEB* | 4-fluoro-N-ethylbuphedrone,2-(ethylamino)-1-(4-fluorophenyl)butan-1-one | x | |||
4F-NEP | 4-fluoro-N-ethylpentedrone | x | |||
4F-PBP | 4-fluoro-α-pyrrolidinobutyrophenone | x | |||
4F-α-PHiP | 4-fluoro-α-pyrrolidinoisohexanophenone | 4-methyl-1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
4F-α-PHP | 4-fluoro-α-pyrrolidinohexanophenone | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | x | ||
5-(2-aminopropyl)benzofuran | 5-APB | 1-(1-benzofuran-5-yl)propan-2-amine | x | ||
5-(2-Aminopropyl)indole | 5-IT 5-API | 1-(1H-indol-5-yl)propan-2-amine | x | ||
5Cl-AKB-48 | N-(adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5Cl-APINACA | N-(1-adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5Cl-AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5-DBFPV | 5-dihydrobenzofuranpyrovalerone | x | |||
5-EAPB | 5-(N-ethyl-2-aminopropyl)benzofuran | x | |||
5F-AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide | x | |||
5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
5F-AKB-48 | 5F-APINACA | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazol-3- carboxamid | PII | ||
5F-AKB-57 | adamantyl-1-(5-fluoropentyl)-1H-indazol-3-carboxylate | x | |||
5F-AMB-PICA | N-(1-methoxycarbonyl-2-methylpropyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
5F-CUMYL-PeGACLONE | 2-(2-phenylpropan-2-yl)-5-(5-fluoropentyl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | x | |||
5F-EDMB-PINACA | ethyl-2-[1-(5-fluoropentyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
5F-MDMB-PICA | methyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
5F-MDMB-PINACA | 5F-ADB | N-(1-methoxycarbonyl-2,2-dimethylpropyl)-1-(5- fluoropentyl)-1H-indazol-3-carboxamid | P II | ||
5F-PB-22 | 8-quinolinyl-1-(5-fluoropentyl)-1H-indol-3-carboxylate | PII | |||
5-FUR-144 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | PII | ||
5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine | x | |||
5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine | x | |||
5-MeO-DALT | N,N-diallyl-5-methoxytryptamine | N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1amine | x | ||
5-MeO-DET | N,N-diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine | x | |||
5-MeO-DiPT | 5-methoxy-N,N-diisopropyltryptamine | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan2-amine | x | ||
5-MeO-DMT | 5-methoxy-N,N-dimethyltryptamine | 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | x | ||
5-MeO-EIPT | 5-metoxy-N-ethyl-N-isopropyltryptamine | x | |||
5-MeO-MALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine | x | |||
5-MeO-MET | 5-methoxy-N-methyl-N-ethyltryptamine | x | |||
5-MeO-MiPT | 5-methoxy-N-methyl,N-isopropyltryptamine | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2amine | x | ||
5-MeO-NIPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine | x | |||
5-Metoksymetylon | bk-MMDMA | β-keto-5-metoxy-3,4-methylenedioxymethamphetamine | x | ||
6-(2-aminopropyl)benzofuran | 6-APB | 1-(1-benzofuran-6-yl)propan-2-amine | x | ||
6-allyl-6-norLSD | AL-LAD, 6-allylnorlysergide | 6-allyl-N,N-diethyl-9,10-didehydroergolin-8-carboxamide | x | ||
6-MAM | 6-monoacetylmorphine | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 6-acetate | x | ||
6-methoxy-MDA | 6-methoxy-3,4-methylenedioxyamphetamine | x | |||
7-hydroxymitragynine | Mitragynine hydroxyindolenine | methyl (E)-2-[3-ethyl-7a-hydroxy-8-methoxy- 1,2,3,4,6,7,7a,12b-octahydro-1H-indolo[2,3-a]quinolizin-2yl]-3-methoxyprop-2-enoate | x | ||
A-CHMINACA | N-(1-adamantyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide | x | |||
AB-001 | (1-adamantyl)(1-pentyl-1H-indol-3-yl)methanone | x | |||
AB-CHMINACA | N-(1-aminocarbonyl-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide | PII | |||
AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentylindazole-3-carboxamide | PII | |||
Acetorphine | 4,5-epoxy-7-(1-hydroxy-1-methylbutyl)-6-methoxy-17methyl-6,14-ethenomorphinan-3-yl acetate | N I+IV | x | ||
Acetylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | N I | |||
Acetyldihydrocodeine | 4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl acetate | N II+III | 1) | ||
Acetylmethadol | Methadyl acetate | 6-(dimethylamino)-4,4-diphenylheptan-3-yl acetate | N I | ||
Acrylfentanyl | ACRYLOYLFENTANYL | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide | N I | ||
Acetyl-α-methylfentanyl | α-methylacetylfentanyl | N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4yl]acetamide | N I+IV | ||
ADB-BUTINACA | ADB-BINACA | N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide | x | ||
ADB-CHMINACA | MAB-CHMINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide | P II | ||
ADB-FUBINACA | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazol-3-carboxamide | P II | |||
ADB-4en-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide | x | |||
Adinazolam | 1-(6-phenyl-8-chloro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | x | 4) | ||
AH-7921 | 3,4-dichloro-N-[[1- (dimethylamino)cyclohexyl]methyl]benzamide | x | |||
ALD-52 | 1-acetyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide | x | |||
Alfentanil | N-[1-[2-(4-ethyl-5-oxo-4,5dihydro-1H-tetrazol-1-yl)ethyl]-4(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide | NI | |||
Allobarbital | Allobarbitone | 5,5-bis(prop-2-enyl)-1,3-diazinane-2,4,6-trione | P IV | x | |
Allylescaline | 4-allyloxy-3,5-dimethoxyphenethylamine | 2-(3,5-dimethoxy-4-prop-2-enoxyphenyl)ethanamine | x | ||
Allylprodine | 1-methyl-4-phenyl-3-prop-2-enylpiperidin-4-yl propionate | N I | |||
Alphacetylmethadol (AAM) | [(3R,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate | N I | |||
Alphameprodine | α-meprodine | [(3S,4R)-3-ethyl-1-methyl-4-phenylpiperidin-4-yl] propanoate | N I | ||
Alphamethadol | α-methadol Alfametadol | (3R,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-ol | N I | ||
Alphaprodine | [(3R,4S)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate | N I | |||
Alprazolam | 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | P IV | |||
AM-1220 | [1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3yl](naphthalen-1-yl)methanone | x | |||
AM-2201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole | 1-[(5-fluoropentyl)-1H-indol-3-yl](naphthalen-1yl)methanone | P II | x | |
AM-2201 chlorine analog | (1-(5-chloropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
AM-2201 N-(3-fluoropentyl) isomer | (1-(3-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
AM-2233 | (2-iodophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]-1Hindol-3-yl]methanone | x | |||
AM-679 | (1-pentyl-1H-indol-3-yl)(2-iodophenyl)methanone | x | |||
AM-694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole | 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone | x | ||
AMB-CHMINACA | methyl-2-([1-(cyclohexylmethyl)-1H-indazol-3-carbonyl]amino)-3-methylbutanoate | x | |||
AMB-FUBINACA | MMB-FUBINACA, FUB-AMB | N-(1-methoxycarbonyl-2-methylpropyl)-1-(p-fluorobenzyl)-1H-indazol-3-carboxamide | PII | x | |
Amfepramone | Diethylpropion Diethylcathinone | 2-(diethylamino)-1-phenylpropan-1-one | P IV | ||
Amineptine | 7-[(10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5yl)amino]heptanoic acid | P II | |||
Aminorex | 5-phenyl-4,5-dihydro-1,3-oxazol-2-amine | P IV | |||
Amobarbital | Amylobarbitone | 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione | P III | ||
Amphetamine | Amfetamín (íslenska) | 1-phenylpropan-2-amine | P II | x | 4) |
Amphetaminil | 2-phenyl-2-(1-phenylpropanyl-2-amino)acetonitrile | x | |||
Amyl nitrite | Allir isomerar | Pentyl nitrite | x | ||
Anileridine | ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4carboxylate | N I | |||
Apinaca | N-(1-adamantyl)-1-pentyl-1H-indazol-3-carboxamide | x | |||
Aprobarbital | Aprobarbitone Allylpropymal | 5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | x | 4) | |
Barbital | Barbitone | 5,5-diethyl-1,3-diazinane-2,4,6-trione | P IV | ||
Bentazepam | Thiadipone | 1,3,6,7,8,9-hexahydro-5-phenyl--2H-[1]-benzothieno[2,3-e]- 1,4-diazepin-2-one | x | ||
Benzethidine | ethyl 4-phenyl-1-(2-(benzyloxy)ethyl)piperidine-4carboxylate | N I | |||
Benzodioxole-fentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide | x | |||
Benzoylbenzylfentanyl | N-(1-benzylpiperid-4-yl)-N-phenylbenzamide | x | |||
Benzoylecgonin | (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid | x | |||
Benzoylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-benzamid | x | |||
Benzylfentanyl | N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide | x | |||
Benzphetamine | Benzylamphetamine | N-benzyl-N-methyl-1-phenylpropan-2-amine | P IV | ||
Benzylmorphine | Peronine | 3-(benzyloxy)-7,8-didehydro-4,5-epoxy-17methylmorphinan-6-ol | N I | ||
Benzylpiperazine | BZP | 1-benzylpiperazine | P II | x | |
Betacetylmethadol | [(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate | N I | |||
Betameprodine | [(3R,4R)-3-ethyl-1-methyl-4-phenylpiperidin-4-yl] propanoate | N I | |||
Betamethadol | betametadol β-methadol | (3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-ol | N I | ||
Betaprodine | [(3R,4R)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate | N I | |||
Bezitramide | 4-[4-(2-oxo-3-propanoylbenzimidazol-1-yl)piperidin-1-yl]- 2,2-diphenylbutanenitrile | N I | |||
bk-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone | x | |||
bk-3,4-MDPA | Propylon | β-keto-3,4-methylenedioxypropylamphetamine | x | ||
bk-6-metoxy-MDMA | N-Methyl-bk-MMDA-2; | β-keto-6-metoxy-3,4-methylenedioxymethamphetamine | x | ||
bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-one | x | |||
bk-IVP | 1-(2,3-dihydro-1-inden-5-yl)-2-(ethylamino)pentan-1-one | x | |||
bk-MDEA | β-keto-methylenedioxy-N-ethylamphetamine | x | |||
bk-MDMA | β-keto-3,4-methylenedioxymethamphetamine | P II | |||
bk-PBDB | β-keto-N-propylbenzodioxolylbutanamine | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one | x | ||
BMDB* | 2-benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one | x | |||
BMDP | 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one | x | |||
Brallobarbital | Brallobarbitone | 5-(2-bromoprop-2-en-1-yl)-5-(prop-2-en-1-yl)-1,3-diazinane2,4,6-trione | x | ||
Bromadoline | 4-bromo-N-[2-(dimethylamino)cyclohexyl]benzamide | x | |||
Bromazepam | Heptabarbitone | 7-bromo-1,3-dihydro-5-(pyridin-2-yl)-2H-1,4-benzodiazepin2-one | P IV | ||
Bromazolam | 8-bromo-6-phenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
Bromo-DragonFLY | Bromo-benzodifuranyl-isopropylamine | 1-(4-bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine | x | ||
Bromo-STP | 2-(3-bromo-2,5-dimethoxy-4-methylphenyl)ethanamine | x | |||
Brotizolam | 2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine | P IV | x | ||
Bufotenin | 5-HO-DMT N,N-dimethyl-5-hydroxytryptamine N,N-dimethylserotonin | 3-[2-(dimethylamino)ethyl]-1H-indol-5-ol | x | ||
Buphedrone | α-methylamino-butyrophenone MABP | 2-methylamino-1-phenylbutan-1-one | x | ||
Buprenorphine | 17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol | P III | |||
Butabital | 5-(2-methylpropyl)-5-(prop-2-enyl)-1,3-diazinane-2,4,6trione | P III | |||
Butobarbital | Butobarbitone Butethal | 5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione | P IV | x | |
Butylone | β-keto-N-methylbenzodioxolylbutanamine bk-MBDB | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one | x | ||
Butyrfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide | N I | |||
C30-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine | x | |||
Camazepam | 7-chloro-1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4benzodiazepin-3-yl N,N-dimethylcarbamate | P IV | |||
Cannabis | Kannabis, Hass, Marijuana, Marihuana | N I+IV | x | ||
Cannabis-harpix | Kannabis harpix | N I+IV | x | ||
Carfentanil | Carfentanyl | Methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate | N IV | ||
Carisoprodol | [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2ylcarbamate | x | 4) | ||
Cathine | (+)-Norpseudoephedrine D-Norpseudoephedrine | 2-amino-1-phenylpropan-1-ol | P III | x | |
Cathinone | Benzoylethanamine Hagigat | 2-amino-1-phenylpropan-1-one | P I | x | |
CB-13 | SAB-378 CRA-13 | naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone | x | ||
Chloral hydrate | Chlorali hydras | 2,2,2-trichloroethane-1,1-diol | x | ||
Chloralodol | Chlorhexadol | 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)pentan-2-ol | x | ||
Chlordiazepoxide | 7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine 4-oxide | P IV | |||
Chloro-isobutyrylfentanyl | N-(2-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide N-(3-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide | x | |||
Chlorphentermine | 1-(4-chlorophenyl)-2-methylpropan-2-amine | x | |||
Clobazam | 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione | P IV | |||
Clobenzorex | N-[(2-chlorophenyl)methyl]-1-phenylpropan-2-amine | x | 4) | ||
Clomethiazole | Chlormethiazole | 5-(2-chloroethyl)-4-methyl-1,3-thiazole | x | 4) | |
Clonazepam | 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4benzodiazepin-2-one | P IV | |||
Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Cloniprazepam | 1-(cyclopropylmethyl)-5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-[1,4]- benzodiazepin-2-one | x | |||
Clonitazene | 2-[2-[(4-chlorophenyl)methyl]-5-nitrobenzimidazol-1-yl]- N,N-diethylethanamine | N I | |||
Clorazepate | Clorazepate | 7-chloro-1,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine3-carboxylic acid | P IV | ||
Clotiazepam | 5-(2-chlorophenyl)-7-ethyl-1-methyl-2H-thieno[2,3e][1,4]diazepin-2-one | P IV | |||
Cloxazolam | 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro- [1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one | P IV | |||
Coca blöð | Folium coca | N I | x | ||
Cocaine | Benzoylmethylecgonine | Methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4carboxylate | N I+III | x | |
Codeine | 3-methylmorphine | 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6ol | N II+III | 1) | |
Codeine-N-oxide | Genocodeine | 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6ol 17-oxide | N I | x | |
Codoxime | Codossima | (Epoxy-3-methoxy-17-methylmorphinan-6ylidene)amino)oxy)acetic acid | N I | ||
CP 47,497-C6 | CP 47,497 dimethylhexyl homologue | 2-[3-hydroxycyclohexyl]-5-(2-methylheptan-2-yl)phenol | x | ||
CP 47,497-C7 | CP 47,497 | 2-[3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol | x | ||
CP 47,497-C8 | Cannabicyclohexanol CP 47,497 dimethyloctyl homologue | 2-[3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol | x | ||
CP 47,497-C9 | CP 47,497 dimethylnonyl homologue | 2-[3-hydroxycyclohexyl]-5-(2-methyldecan-2-yl)phenol | x | ||
CP 55,940 | 2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2methyloctan-2-yl)phenol | x | |||
Crotonylfentanyl | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | x | |||
CUMYL-4CN-BINACA | N-(1-methyl-1-phenylethyl)-1-(4-cyanobutyl)-1H-indazol-3-carboxamide | P II | |||
CUMYL-5F-P7AICA | N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-7-azaindol-3-carboxamid | x | |||
CUMYL-5F-PINACA | N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide | x | |||
CUMYL-CHMGACLONE | 5-(cyclohexylmethyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | x | |||
CUMYL-PeGACLONE | 2-(2-phenylpropan-2-yl)-5-pentyl-2,5-dihydro-1H-pyrido[4,3- b]indol-1-one | x | |||
CUMYL-PICA | N-(2-phenylpropan-2-yl)-1-pentyl-1H-indol-3-carboxamide | x | |||
Cyclobarbital | Cyclobarbitol Cyclobarbitone | 5-(cyclohexen-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | P III | ||
Cyclopentylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]cyclopentanecarboxamide | x | |||
Cyclopropylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide | N I | |||
Delorazepam | Chlordesmethyldiazepam | 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4benzodiazepin-2-one | P IV | ||
Deschloroetizolam | 2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Deschloro-N-ethylnorketamine | O-PCE | 2-(ethylamino)-2-phenylcyclohexan-1-one | x | ||
Desmethylprodine | MPPP 1-Methyl-4-phenyl-4-propionoxypiperidine | 1-methyl-4-phenylpiperidin-4-yl propionate | N I+IV | ||
Desomorphine | Dihydrodesoxymorphine „Krokodil“ | 4,5-epoxy-17-methylmorphinan-3-ol | N I+IV | x | |
Desoxy-D2PM | 2-(diphenylmethyl)pyrrolidine | x | |||
Desoxypipradrol | 2-diphenylmethylpiperidine 2-DPMP | 2-benzhydrylpiperidine | x | ||
Despropionylfluorofentanyl | N-(2-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine N-(3-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine N-(4-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine | x | |||
Dextroamphetamine | Dexamphetamine | (2S)-1-phenylpropan-2-amine | P II | x | 4) |
Dextromoramide | (3S)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1ylbutan-1-one | N I | |||
Dextropropoxyphene | 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate | N II+III | 3) | ||
Diampromide | N-[2-[methyl(2-phenylethyl)amino]propyl]-Nphenylpropanamide | N I | |||
Diazepam | 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one | P IV | |||
Dibenzylpiperazine | DBZP | 1,4-dibenzylpiperazine | x | ||
Dibutylone | β-keto-dimethylbenzodioxolylbutanamine bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)butan-1-one | x | ||
Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one | x | |||
Dichloropane | RTI-111 | methyl-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-carboxylate | x | ||
Diethylthiambutene | N,N-diethyl-4,4-dithien-2-ylbut-3-en-2-amine | N I | |||
Diethyltryptamine | DET N,N-diethyltryptamine | N,N-diethyl-2-(1H-indol-3-yl)ethanamine | P I | x | |
Difenoxin | Motofen | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4carboxylic acid | N I+III | ||
Dihydrocodeine | 4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol | N II+III | 1) | ||
Dihydroetorphine | 7-[2-Hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy- 6,14-ethanomorphinan-3-ol | N I | x | ||
Dihydromorphine | Paramorfan Paramorphan | 3,6-dihydroxy-4,5-epoxy-17-methylmorphinan | N I | ||
Dimenoxadol | Dimenoxadole | 2-(dimethylamino)ethyl 2-ethoxy-2,2-diphenylacetate | N I | ||
Dimepheptanol | Methadol Racemethadol | 6-dimethylamino-4,4-diphenylheptan-3-ol | N I | ||
Dimethocaine | [3-(diethylamino)-2,2-dimethylpropyl] 4-aminobenzoate | x | |||
Dimethoxyamphetamine | DMA | 1-(2,3-dimethoxyphenyl)propan-2-amine | P I | x | |
Dimethylheptylpyran | DMHP | 6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10tetrahydrobenzo[c]chromen-1-ol | P I | x | |
Dimethylone | β-keto-3,4-metylendioksydimetylamfetamin bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one | x | ||
Dimethylthiambutene | DMTB | N,N-dimethyl-4,4-dithien-2-ylbut-3-en-2-amine | N I | ||
Dimethyltryptamine | DMT N,N-dimethyltryptamine | 2-(1H-indol-3-yl)-N,N-dimethylethanamine | P I | x | |
Dioxaphetyl butyrate | ethyl 4-morpholin-4-yl-2,2-diphenylbutanoate | N I | |||
Dipentylon | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | x | |||
Diphenidine | difenidin | 1-(1,2-diphenylethyl)piperidine | x | ||
Diphenoxylate | ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4carboxylate | N I+III | 2) | ||
Dipipanone | 4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one | N I | |||
Dipropyltryptamine | DPT N,N-dimethylpropyltryptamine | N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | x | ||
DiPT | N,N-diisopropyltryptamine | N-[2-(1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine | x | ||
DL-4662 | 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one | x | |||
DOPR | 2,5-dimethoxy-4-propylamphetamine | x | |||
DOT | 2,5-dimethoxy-4-methylthioamphetamine | x | |||
Dronabinol | (−)-trans-Δ9-tetrahydrocannabinol og stereoisomerar | 6,6,9-trimethyl-3-pentyl-6a,7,8,10atetrahydrobenzo[c]chromen-1-ol | P II | x | 4) |
Drotebanol | Oxymethebanol | 3,4-dimethoxy-17-methylmorphinan-6,14-diol | N I | ||
EAM-2201 | (4-ethylnaphthalen-1-yl)-[1-(5-fluoropentyl)indol-3-yl]methanone | x | |||
Ecgonine | Ásamt estum og afbrigðum þeirra sem hægt er að breyta í ecgonin eða kókaín, þ.m.t. benzoyl-, ethyl- og methyl-ecgonine | 3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid | N I | x | |
Eflea | N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-yl]-N-methylhydroxylamine | x | |||
Ephenidine | N-ethyl-1,2-diphenylethylamine | x | |||
Escaline | 3,5-dimethoxy-4-ethoxyphenylethylamine | 2-(4-ethoxy-3,5-dimethoxyphenyl)ethanamine | x | ||
Etazene | Etodesnitazene | 2-[2-[(4-ethoxyphenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamine | x | ||
Estazolam | 8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | P IV | |||
Etaqualone | 3-(2-ethylphenyl)-2-methylquinazolin-4(3H)-one | x | |||
ETH-LAD | N,N,6-triethyl-9,10-didehydroergoline-8-carboxamide | x | |||
Ethcathinone | N-ethylaminopropiophenone N-ethylcathinone | 2-ethylamino-1-phenylpropan-1-one | x | ||
Ethchlorvynol | 1-chloro-3-ethylpent-1-en-4-yn-3-ol | P IV | |||
Ethinamate | 1-ethynylcyclohexyl carbamate | P IV | |||
Ethyl loflazepate | ethyl 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4benzodiazepine-3-carboxylate | P IV | |||
Ethylamphetamine | Etilamfetamine N-ethylamphetamine | N-ethyl-1-phenylpropan-2-amine | P IV | x | |
Ethylmethylthiambutene | Emethibutin | N-ethyl-N-methyl-4,4-dithien-2-ylbut-3-en-2-amine | N I | ||
Ethylmorphine | Dionine Codethyline | 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol | N II+III | 1) | |
Ethylon | etylon, ethylone | 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-on | P II | ||
Ethylphenidate | ethyl 2-phenyl-2-piperidin-2-ylacetate | P II | |||
Eticyclidine | PCE | N-ethyl-1-phenylcyclohexan-1-amine | P I | x | |
Etizolam | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | 4) | ||
Etonitazene | 2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]- N,N-diethylethanamine | N I | |||
Etorphine | M99 | 7-[2-Hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy- 6,14-ethenomorphinan-3-ol | N I+IV | x | |
Etoxeridine | Carbetidine | ethyl 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4carboxylate | N I | ||
Etryptamine | α-Ethyltryptamine α-ET | 1-(1H-indol-3-yl)butan-2-amine | P I | x | |
Eutylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-butanone | x | |||
Fencamfamine | N-ethyl-2-phenylbicyclo[2.2.1]heptan-3-amine | P IV | |||
Fenethylline | Phenethylline | 1,3-dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]purine2,6-dione | P II | x | |
Fenfluramine | 3-trifluoromethyl-N-ethylamphetamine | N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine | x | ||
Fenproporex | 3-(1-phenylpropan-2-ylamino)propanenitrile | P IV | |||
Fentanyl | Fentanil | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | N I | ||
Flephedrone | 4-fluoromethcathinone 4-FMC | 1-(4-fluorophenyl)-2-(methylamino)propan-1-one | x | ||
Flualprazolam | 6-(2-fluorophenyl)-8-chloro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
Flubromazepam | 7-bromo-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one | x | |||
Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Fludiazepam | 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4benzodiazepin-2-one | P IV | |||
Flunitrazepam | Rohypnol Rohipnol | 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2one | P III | ||
Fluorobutyrylfentanyl | N-(2-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid N-(3-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid N-(4-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid | x | |||
Fluoro-isobutyrylfentanyl | N-(2-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid N-(3-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid | NI | |||
Flurazepam | 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one | P IV | |||
FUB-144 | (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | x | |||
Furanylethylfentanyl | N-[1-[2-(2-furanyl)ethyl]piperidin-4-yl]-N-phenyl-propanamide | x | |||
Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide | N I | |||
Furethidine | ethyl 1-[2-(oxolan-2-ylmethoxy)ethyl]-4-phenylpiperidine-4carboxylate | N I | |||
Gamma-Butyrolactone | GBL 4-butyrolactone | oxolan-2-one | x | 5) | |
Gamma-hydroxybutyrate | GHB, Sodium Oxybate | 4-hydroxybutanoate | x | 4) | |
Gamma-hydroxybutyric acid | GHB, smjörsýra | 4-hydroxybutanoic acid | P IV | x | |
Glutethimide | 3-ethyl-3-phenylpiperidine-2,6-dione | P III | |||
Halazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H- 1,4-benzodiazepin-2-one | P IV | |||
Haloxazolam | 10-bromo-11b-(2-fluorophenyl)-2,3,5,7-tetrahydro- [1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one | P IV | |||
Heptabarbital | Heptabarbitone Heptabarb | 5-(1-cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | x | 4) | |
Heroin | Diacetylmorphine Morphine diacetate Diamorphine | 3-acetoxy-7,8-didehydro-4,5-epoxy-17-methylmorphinan-6-yl acetate | N I+IV | x | |
Hexapropymate | 1-(prop-2-ynyl)cyclohexyl carbamate | x | 4) | ||
Hexedrone | 2-methylamino-1-phenylhexan-1-one | x | |||
Hexobarbital | Hexobarbitone | 5-(1-cyclohexen-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6trione | x | 4) | |
HU-210 | 11-Hydroxy-Δ-8-THC-DMH | 9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol | x | ||
HU-308 | 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol | x | |||
Hydrocodone | 4,5-epoxy-3-methoxy-17-methylmorphinan-6-one | N I | |||
Hydromorphinol | 14-Hydroxydihydromorphine | 3,6,14-trihydroxy-4,5-epoxy-17-methylmorphinan | N I | ||
Hydromorphone | Dihydromorphinone | 4,5-epoxy-3-hydroxy-17-methyl morphinan-6-one | N I | ||
Hydroxyamphetamine | 4-hydroxyampetamine | 4-(2-aminopropyl)phenol | x | ||
Hydroxypethidine | Bemidone | ethyl 4-(3-hydroxyphenyl)-1-methylpiperidine-4-carboxylate | N I | ||
I-AMB | methyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]carboxamido)-3- methylbutanoate | x | |||
Iboga | Tabernanthe iboga | x | |||
Ibogaine | 12-methoxyibogamine | x | |||
Isobutyl nitrite | 2-methylpropyl nitrite | x | |||
Isomethadone | Isoamidone | 6-(dimethylamino)-5-methyl-4,4-diphenylhexan-3-one | N I | ||
isopropylphenidate | Isopropyl-2-phenyl-2-(piperidin-2-yl)acetate | x | |||
Isopropyl-U-47700 | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine | x | |||
Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine | NI | x | ||
JWH-007 | (2-methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1yl)methanone | x | |||
JWH-011 | (1-(heptan-2-yl)-2-methyl-1H-indol-3-yl)(naphthalen-1yl)methanone | x | |||
JWH-015 | (2-methyl-1-propyl-1H-indol-3-yl)(naphthalen-1yl)methanone | x | |||
JWH-016 | (1-butyl-2-methyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-018 | AM-678 | (naphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | P II | x | |
JWH-018, N-(5-chloropentyl) analog | [1-(5-chloropentyl)-1H-indol-3-yl](naphthalen-1yl)methanone | x | |||
JWH-019 | (1-hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-020 | (1-heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-022 | (naphthalen-1-yl)[1-(pent-4-en-1-yl)-1H-indol-3yl]methanone | x | |||
JWH-030 | (naphthalen-1-yl)(1-pentyl-1H-pyrrol-3-yl)methanone | x | |||
JWH-031 | (1-hexyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-047 | (1-butyl-2-methyl-1H-indol-3-yl)(7-methylnaphthalen-1yl)methanone | x | |||
JWH-048 | (2-methyl-1-pentyl-1H-indol-3-yl)(7-methylnaphthalen-1yl)methanone | x | |||
JWH-071 | (1-ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-072 | (naphthalen-1-yl)(1-propyl-1H-indol-3-yl)methanone | x | |||
JWH-073 | (1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-081 | (4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3yl)methanone | x | |||
JWH-098 | (4-methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3yl)methanone | x | |||
JWH-116 | (2-ethyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
JWH-120 | (4-methylnaphthalen-1-yl)(1-propyl-1H-indol-3-yl)mehtanone | x | |||
JWH-122 | (4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | x | |||
JWH-145 | (naphthalen-1-yl)(1-pentyl-5-phenyl-1H-pyrrol-3yl)methanone | x | |||
JWH-147 | (1-hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1yl)methanone | x | |||
JWH-148 | (4-methylnaphthalen-1-yl)(2-methyl-1-propyl-1H-indol-3yl)methanone | x | |||
JWH-149 | (4-methylnaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3yl)methanone | x | |||
JWH-164 | (7-methoxynaphthalen-1-yl)-(1-pentyl-1H-indol-3yl)methanone | x | |||
JWH-166 | (6-methoxynaphthalen-1-yl)-(1-penty-1H-lindol-3yl)methanone | x | |||
JWH-167 | 1-(1-pentyl-1H-indol-3-yl)-2-phenylethan-1-one | x | |||
JWH-171 | (Z)-1-((3-pentyl-1H-inden-1-ylidene)methyl)naphthalen | x | |||
JWH-175 | 3-(naphthalen-1-ylmethyl)-1-pentyl-1H-indole | x | |||
JWH-176 | (E)-1-((3-pentyl-1H-inden-1-ylidene)methyl)naphthalen | x | |||
JWH-180 | (1-propyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone | x | |||
JWH-181 | (2-methyl-1-pentyl-1H-indol-3-yl)(4-propylnaphthalen-1yl)methanone | x | |||
JWH-182 | (1-pentyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone | x | |||
JWH-184 | 3-((4-methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole | x | |||
JWH-185 | 3-((4-methoxynaphthalen-1-yl)methyl)-1-pentyl-1H-indole | x | |||
JWH-192 | 4-(2-(3-((4-methylnaphthalen-1-yl)methyl)-1H-indol-1yl)ethyl)morpholine | x | |||
JWH-193 | (4-methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H-indol- 3-yl)methanone | x | |||
JWH-194 | 2-methyl-3-((4-methylnaphthalen-1-yl)methyl)-1-pentyl-1Hindole | x | |||
JWH-195 | 4-(2-(3-(naphthalen-1-ylmethyl)-1H-indol-1yl)ethyl)morpholine | x | |||
JWH-196 | 2-methyl-3-(naphthalen-1-ylmethyl)-1-pentyl-1H-indole | x | |||
JWH-197 | 3-((4-methoxynaphthalen-1-yl)methyl)-2-methyl-1-pentyl1H-indole | x | |||
JWH-198 | (4-methoxynaphthalen-1-yl)(1-(2-morpholinoethyl)-1H-indol- 3-yl)methanone | x | |||
JWH-199 | 4-(2-(3-((4-methoxynaphthalen-1-yl)methyl)-1H-indol-1yl)ethyl)morpholine | x | |||
JWH-200 | WIN-55,225 | [1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl](naphthalen-1yl)methanone | x | ||
JWH-201 | 2-(4-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | x | |||
JWH-203 | 2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | x | |||
JWH-205 | 1-(2-methyl-1-pentyl-1H-indol-3-yl)-2-phenylethan-1-one | x | |||
JWH-210 | (4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | x | |||
JWH-250 | 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | x | |||
JWH-251 | 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | x | |||
JWH-308 | naphthalen-1-yl[5-(4-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]methanone | x | |||
JWH-309 | naphthalen-1-yl[5-(1-naphthalenyl)-1-pentyl-1H-pyrrol-3-yl]-methanone | x | |||
JWH-368 | naphthalen-1-yl(5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)methanone | x | |||
JWH-369 | [5-(2-chlorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | x | |||
JWH-398 | (4-chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | x | |||
Kaktusar sem innihalda mescaline | Kaktus og fræ af tegundunum Ecinopsis pachanoi og Ecinopsis peruviana og aðrar sem innihalda mescaline (3,4,5-trimethoxyphenethylamine) | x | |||
Ketamine | 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one | x | 4) | ||
Ketazolam | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-6H- [1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione | P IV | |||
Ketobemidone | Cliradon Cymido Ketorax | 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]propan-1-one | N I+IV | x | 4) |
Khat | Catha edulis, Allir hlutar plöntunnar | x | |||
Kratom | Mitragyna speciosa | x | |||
Lefetamine | SPA | N,N-dimethyl-1,2-diphenylethanamine | P IV | x | |
Levoamphetamine | Levamfetamine (R)-amphetamine (−)-amphethamine | (2R)-1-phenylpropan-2-amine | P II | x | |
Levomethamphetamine | Levmetamfetamine Levodesoxyephedrine (l-desoxyephedrine) | (2R)-N-methyl-1-phenylpropan-2-amine | P II | x | |
Levomethorphan | (1R,9R,10R)-4-methoxy-17-methyl-17- azatetracyclo[7.5.3.0¹,¹⁰.0²,⁰]heptadeca-2,4,6-triene | N I | |||
Levomoramide | (3R)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1ylbutan-1-one | N I | |||
Levonantradol | CP 50,556-1 | 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy- 5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate | x | ||
Levophenacylmorphan | Benzorphanol | 2-(3-Hydroxymorphinan-17-yl)-1-phenylethanone | N I | ||
Levorphanol | N I | ||||
Lisdexamfetamine | 2,6-diamino-N-(1-phenylpropan-2-yl)hexanamide | x | 4) | ||
Lofentanil | methyl (3S,4R)-3-methyl-1-(2-phenylethyl)-4- [phenyl(propionyl)amino]piperidin-4-carboxylat | x | |||
Loprazolam | Triazulenone Loprazolam mesylate | 6-(2-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1piperazinyl)methylene]-8-nitro-1H-imidazo[1,2a][1,4]benzodiazepine-1-one | P IV | ||
Lorazepam | 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4benzodiazepin-2-one | P IV | |||
Lormetazepam | methyl-lorazepam | 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1methyl-2H-1,4-benzodiazepin-2-one | P IV | ||
LSZ | 8b-(2,4-dimethylazetidin-1-yl)carbonyl-9,10-didehydro-6-methylergoline | x | |||
Lysergic Acid Diethylamide | Lysergide LSD LSD-25 | N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3fg]quinoline-9-carboxamide | P I | x | |
MAM-2201 | (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalen-1yl)methanone | x | |||
MAM-2201 klór analog | (1-(5-chloropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | x | |||
MAM-2201 N-(3-fluoropentyl) analog | (1-(3-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | x | |||
Mazindol | Mazanor Sanorex | 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol | P IV | x | |
MDAI | 5,6-methylenedioxy-2-aminoindane | (6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine) | x | ||
MDMA | 3,4-methylenedioxy-N-methylamphetamine „Ecstasy“, „Alsæla“, „Molly“ | 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine | P I | x | |
MDMB-4en-PINACA | methyl-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazol-3- carboxamido]butanoate | x | |||
MDMB-CHMICA | (methyl-2-(1-(cyclohexylmethyl)-1H-indol-3-carboxamido)-3,3-dimethylbutanoat) | PII | |||
MDMB-CHMINACA | methyl-2-([1-(cyclohexylmethyl)-1H-indazol-3-carbonyl]amino)-3,3-dimethylbutanoate | x | |||
MDPBP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | x | |||
MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | x | |||
Meclonazepam | 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-one | x | |||
Mecloqualone | Nubarene Casfen | 3-(2-chlorophenyl)-2-methylquinazolin-4-one | P II | x | |
Medazepam | 7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4benzodiazepine | P IV | |||
Mefenorex | N-(3-chloropropyl)-1-phenylpropan-2-amine | P IV | |||
MeO-diphenidine | 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine 1-(1-(3-methoxyphenyl)-2-phenylethyl)piperidine 1-(1-(4-methoxyphenyl)-2-phenylethyl)piperidine | x | |||
MeO-PCP | 1-(1-(2-methoxyphenyl)cyclohexyl)piperidine 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine 1-(1-(4-methoxyphenyl)cyclohexyl)piperidine | x | |||
Mephedrone | 4-methylmethcathinone 4-MMC 4-methylephedrone | 2-(methylamino)-1-(4-methylphenyl)propan-1-one | P II | x | |
Meprobamate | 2-(carbamoyloxymethyl)-2-methylpentyl carbamate | P IV | |||
Mescaline | 3,4,5-trimethoxyphenethylamine | 2-(3,4,5-trimethoxyphenyl)ethanamine | P I | x | |
Mesocarb | Sidnocarb Sydnocarb | N-phenyl-N'-[3-(1-phenylpropan-2-yl)oxadiazol-3-ium-5yl]carbamimidate | P IV | ||
MET | N-methyl-N-ethyltryptamine | x | |||
meta-chlorophenylpiperazine | mCPP | 1-(3-chlorophenyl)piperazine | x | ||
Metamfepramone | Dimepropion | 2-dimethylamino-1-phenylpropan-1-one | x | 4) | |
Metazocine | Methobenzmorphan | 1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-2,6-methano-3benzazocin-8-ol | N I | ||
Methacrylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylmethacrylamide | x | |||
Methadone | Dolophine Amidone Physeptone | 6-dimethylamino-4,4-diphenylheptan-3-one | N I | ||
Methadone intermediate | Premethadone | 4-dimethylamino-2,2-diphenylpentanenitrile | N I | ||
Methallylescaline | MAL | 2-[3,5-dimethoxy-4-(2-methylprop-2-enoxy)phenyl]ethanamine | x | ||
Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | x | |||
Methamphetamine | N-methylamphetamine Pervertine „Meth“ N-methyl-alpha-methylphenethylamine | N-methyl-1-phenylpropan-2-amine | P II | x | |
Methamphetamine racemate | Methamfetamine racemate | methyl[(2RS)-1-phenylpropan-2-yl]amine | P II | x | |
Methaqualone | Metolquizolone | 2-methyl-3-(2-methylphenyl)quinazolin-4-one | P II | x | |
Metharbital | Endiemal | 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione | x | 4) | |
Methcathinone | Ephedrone α-methylaminopropiophenone | 2-(methylamino)-1-phenylpropan-1-one | P I | x | |
Methedrone | Para-methoxymethcathinone bk-PMMA PMMC | 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one | x | ||
Methiopropamine | MPA | N-methyl-1-(thiophen-2-yl)propan-2-amine | P II | ||
Methohexital | Methohexitone | 5-(hex-3-yn-2-yl)-1-methyl-5-(prop-2-en-1-yl)-1,3-diazinane2,4,6-trione | x | 4) | |
Methoxetamine | MXE 3-MeO-2-Oxo-PCE | 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | x | ||
Methoxyacetylfentanyl | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | N I | |||
Methoxybutyrylfentanyl | N-(2-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid N-(3-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid | x | |||
Methylclonazepam | 5-(2-chlorophenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
Methyldesorphine | 6,17-dimethyl-6,7-didehydro-4,5-epoxymorphinan-3-ol | N I | |||
Methyldihydromorphine | Dihydroheterocodeine | 6-Methoxy-17-methyl-4,5-epoxymorphinan-3-ol | N I | ||
Methylenedioxypyrovalerone | MDPV | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | P II | x | |
Methylnaphthidate | HDMP-28 | methyl-naphthalen-2-yl(piperidin-2-yl)acetate | x | ||
Methylone | β-keto-3,4-methylendioxymethamphetamine bk-MDMA | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | P II | x | |
Methylpentynol | 3-methylpentl-1-yn-3-ol | x | 4) | ||
Methylphenidate | Phenidylate | methyl 2-phenyl-2-(piperidin-2-yl)acetate | P II | x | 4) |
Methylphenobarbital | Mephobarbital Mephobarbitone | 5-ethyl-1-methyl-5-phenyl-1,3-diazinane-2,4,6-trione | P IV | ||
Methyprylon | 3,3-diethyl-5-methylpiperidine-2,4-dione | P IV | |||
Metizolam | 4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Metopon | 5-methyldihydromorphone | 4,5-epoxy-3-hydroxy-5,17-dimethylmorphinan-6-one | N I | ||
MFPVP | 3-Me-4F-PVP | 1-(4-fluoro-3-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
Midazolam | 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine | P IV | |||
MIPT | N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | x | |||
Mitragynine | Methyl (E)-2-(3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate | x | |||
MMB-022 | AMB-4en-PICA | methyl-3-methyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-carboxamido]butanoate | x | ||
MMB-CHMICA | AMB-CHMICA | methyl-2-[1-(cyclohexylmethyl)-1H-indol-3-carboxamido]-3- methylbutanoate | x | ||
MMB-FUBICA | AMB-FUBICA, FUB-AMB | methyl-2-[1-(4-fluorobenzyl)-1H-indol-3-carboxamido]-3-methylbutanoate | P II | ||
MMDA | 3-methoxy-4,5-methylenedioxyamphetamine 3-methoxy-MDA | 1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine | P I | x | |
MMDA-2 | 6-metoxy-MDA | 6-methoxy-3,4-methylenedioxyamphetamine | x | ||
Modafinil | 2-[(diphenylmethyl)sulfinyl]acetamide | x | 4) | ||
MOPPP* | 4'-methoxy-α-pyrrolidinoproiophenone | x | |||
Moramide-intermediate | 3-methyl-4-(morpholin-4-yl)-2,2-diphenylbutanoic acid | N I | |||
Morpheridine | Morpholinoethylnorpethidine | ethyl 1-[(2-morpholin-4-yl)ethyl]-4-phenylpiperidine-4carboxylate | N I | ||
Morphine | 7,8-didehydro- 4,5-epoxy-17-methylmorphinan-3,6-diol | N I | |||
Morphine methylbromide | Morphine methobromide Morphosan og önnur morfínúrefni með 5-gildu köfnunarefni | 3,6-dihydroxy-17,17-dimethyl-7,8-didehydro-4,5epoxymorphinan-17-ium bromide | N I | ||
Morphine-N-oxide | Genomorphine | 7,8-didehydro- 4,5-epoxy-17-methylmorphinan-3,6-diol 17-oxide | N I | ||
MPHP* | 4-methylphenylpyrrolidinylhexanone | x | |||
MPhP-2201 | methyl-3-phenyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]propanoate | x | |||
MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazin | N I | |||
Myrophine | Myristylbenzylmorphine | 7,8-didehydro-4,5-epoxy-17-methyl-3-(phenylmethoxy)morphinan-6-yl tetradecanoate | N I | ||
Nabilone | 1-hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)- 6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-one | x | 4) | ||
N-acetylmescaline | N-[2-(3,4,5-trimethoxyphenyl)ethyl]acetamide | x | |||
Naphyrone | Naphthylpyrovalerone | 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one | x | ||
N-ethylbuphedrone | NEB | 2-(ethylamino)-1-phenylbutan-1-one | x | ||
N-ethyl-heptedrone | 2-(ethylamino)-1-phenylheptan-1-one | x | |||
N-ethylhexedrone | NEH | 2-(ethylamino)-1-phenyl-hexan-1-one | x | ||
N-ethylisohexedrone | 2-(ethylamino)-4-methyl-1-phenyl-pentan-1-one | x | |||
N-ethylnorketamine | 2-(ethylamino)-2-(2-chlorophenyl)cyclohexan-1-one | x | |||
N-ethylnorpentylone | Efylon, ephylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone | P II | ||
N-ethyl-pentedron | NEP | 2-(ethylamino)-1-phenyl-pentan-1-one | x | ||
N-hydroxy-MDA | N-OH-MDA | N-hydroxy-α-methyl-1,3-benzodioxole-5-ethanamine | x | ||
N-hydroxyamphetamine | N-(1-phenylpropan-2-yl)hydroxylamine | x | |||
Nicocodine | Lyopect Nicocodeine | 3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6yl nicotinate | N II+III | 1) | |
Nicodicodine | Nicodicodeine | 3-methoxy-17-methyl-4,5-epoxymorphinan-6-yl nicotinate | N II+III | 1) | |
Nicomorphine | 7,8-didehydro-4,5-epoxymorphinan-17-methyl-3nicotinoyloxy-6-yl nicotinate | N I | |||
Nifoxipam | 3-hydroxydesmethylflunitrazepam | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one | x | ||
Nimetazepam | 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4benzodiazepin-2-one | P IV | |||
N,N-dimethylpentylon | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone | x | |||
Nitrazepam | 7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one | P IV | |||
Nitrazolam | 6-phenyl-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
NM-2201 | naphthalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-carboxylate | x | |||
N-Methyl-2-AI | N-metyl-2AI, N-methyl-2-aminoindane | N-methyl-2,3-dihydro-1H-inden-2-amine | x | ||
N-methylmescaline | N-methyl-2-(3,4,5-trimethoxyphenyl)ethanamine | x | |||
Noracymethadol | 6-(methylamino)-4,4-diphenylheptan-3-yl acetate | N I | |||
Norcodeine | 7,8-didehydro-4,5-epoxy-3-methoxymorphinan-6-ol | N II+III | 1) | ||
Nordazepam | Desoxydemoxepam Nordiazepam Desmethyldiazepam | 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one | P IV | ||
Norfentanyl | N-phenyl-N-(piperidin-4-yl)propionamide | x | |||
Norfludiazepam | 5-(2-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
Norlevorphanol | morphinan-3-ol | N I | |||
Normethadone | Desmethylmethadone Phenyldimazone | 6-(dimethylamino)-4,4-diphenylhexan-3-one | N I | ||
Normorphine | Desmethylmorphine | 7,8-didehydro-4,5-epoxy-morphinan-3,6-diol | N I | ||
Norpipanone | 4,4-diphenyl-6-(piperidin-1-yl)hexan-3-one | N I | |||
N-Propylnorpentedrone | 1-phenyl-2-(propylamino)pentan-1-one | x | |||
Ocfentanil | ocfentanyl | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide | N I | ||
O-Desmethyltramadol | O-DSMT O-demethyltramadol | 3-[2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol | x | ||
Ohmefentanyl | β-hydroxy-3-methylfentanyl OMF | N-[1-[2-hydroxy-2-phenylethyl]-3-methylpiperidin-4-yl]-Nphenylpropanamide | N I+IV | ||
Opium | Þ.e. hverslags vara úr hrá-ópíum sem unnin er með ýmsum framleiðsluaðferðum, svo sem upplausn, suðu, ristun og gerjun í þeim tilgangi að umbreyta þykkni og gera það hæft til neyslu. Einnig leyfar sem verða eftir við reykingu á ópíum. | N I+III | x | ||
Oripavine | 3-O-demethyl-thebaine | 6,7,8,14-tetradehydro-4,5-epoxy-6-methoxy-17methylmorphinan-3-ol | N I | ||
Ortetamine | 2-methylamphetamine | 1-(2-methylphenyl)propan-2-amine | x | ||
Orthoflurorofentanyl | 2-fluorofentanyl | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-fluorophenyl)propanamide | N I | ||
Oxazepam | 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4benzodiazepin-2-one | P IV | |||
Oxazolam | 10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro- [1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one | P IV | |||
Oxycodone | 4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6one | N I | |||
Oxymorphone | Opana Numorphan | 4,5α-epoxy-3,14-dihydroxy- 17-methylmorphinan-6-one | N I | ||
Parafluorobutyrylfentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4- yl]butanamide | N I | |||
Para-fluorofentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4yl]propanamide | N I+IV | |||
Parahexyl | Synhexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydrobenzo[c]chromen1-ol | P I | x | |
para-Methoxyphenylpiperazine | MeOPP 4-MPP | 1-(4-methoxyphenyl)piperazine | x | ||
Pemoline | 2-amino-5-phenyl-1,3-oxazol-4-one | P IV | x | 4) | |
Pentazocine | 6,11-dimethyl-3-(3-methylbut-2-enyl)-1,2,3,4,5,6-hexahydro- 2,6-methano-3-benzazocin-8-ol | P III | |||
Pentedrone | 1-phenyl-2-(methylamino)pentan-1-one | P II | |||
Pentobarbital | Pentobarbitone | 5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione | P III | ||
Pentylone | 1-(1,3-benzodioxol-5-yl)-2-(metylamino)pentan-1-one | x | |||
PEPAP | 1-(2-phenylethyl)-4-phenyl-4acetoxypiperidine | 4-phenyl-1-(2-phenylethyl)piperidin-4-yl acetate | N I+IV | ||
Pethidine | Meperidine | ethyl 1-methyl-4-phenylpiperidine-4-carboxylate | N I | ||
Pethidine intermediate A | 1-methyl-4-phenylpiperidine-4-carbonitrile | N I | |||
Pethidine intermediate B | Norpethidine Normeperidine | ethyl 4-phenylpiperidine-4-carboxylate | N I | ||
Pethidine intermediate C | Pethidinic acid | 1-methyl-4-phenylpiperidine-4-carboxylic acid | N I | ||
Phenadoxone | 6-(morpholin-4-yl)-4,4-diphenylheptan-3-one | N I | |||
Phenampromide | N-phenyl-N-[(1-piperidin-1-yl)propan-2-yl]propanamide | N I | |||
Phenazepam | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4benzodiazepin-2-one | x | |||
Phenazocine | 6,11-Dimethyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6methano-3-benzazocin-8-ol | N I | |||
Phencyclidine | PCP „Englaryk“ | 1-(1-phenylcyclohexyl)piperidine | P II | x | |
Phendimetrazine | Bontril | 3,4-dimethyl-2-phenylmorpholine | P IV | x | |
Phenmetrazine | Oxazimedrine Preludin | 3-methyl-2-phenylmorpholine | P II | x | |
Phenobarbital | Phenobarbitone | 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione | P IV | ||
Phenomorphan | 17-(2-phenylethyl)morphinan-3-ol | N I | |||
Phenoperidine | ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4carboxylate | N I | |||
Phentermine | Phenyl-tertiary-butylamine | 2-methyl-1-phenylpropan-2-amine | P IV | ||
Phenylisobutylamine | PBA | 1-phenylbutan-2-amine | x | ||
Pholcodine | 7,8-didehydro-4,5-epoxy-17-methyl-3-[2-(morpholin-4yl)ethoxy]morphinan-6-ol | N II+III | 1) | ||
Piminodine | Alvodine | ethyl 1-(3-anilinopropyl)-4-phenylpiperidine-4-carboxylate | N I | ||
Pinazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(prop-2-ynyl)-2H-1,4benzodiazepin-2-one | P IV | |||
Pipradrol | diphenyl(piperidin-2-yl)methanol | P IV | |||
Piritramide | 1-(3-cyano-3,3-diphenylpropyl)-4-(piperidin-1-yl)piperidine- 4-carboxamide | N I | |||
p-MePPP | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one | x | |||
Poppy straw | Valmúastrá ásamt þykkni unnu úr valmúastrái | N I | |||
Prazepam | 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-one | P IV | |||
Pregabalin | (3S)-3-(aminomethyl)-5-methylhexanoic acid | x | 4) | ||
Proheptazine | 1,3-dimethyl-4-phenylazepan-4-yl propionate | N I | |||
Properidine | propan-2-yl 1-methyl-4-phenylpiperidine-4-carboxylate | N I | |||
Propiram | N-(1-(piperidin-1-yl)propan-2-yl)-N-(pyridin-2yl)propanamide | N II+III | |||
Propylphenidate | propyl-2-phenyl-2-(piperidin-2-yl)acetate | x | |||
Propylhexedrine | 1-cyclohexyl-N-methylpropan-2-amine | x | |||
Proscaline | 4-Propoxy-3,5-DMPEA proscaline | 3,5-dimethoxy-4-propoxyphenethylamine | x | ||
Psilocin | Psilotsin 4-OH-DMT 4-Hydroxy-N,N-dimethyltryptamine | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | P I | x | |
Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate | P I | x | ||
PV9 | α-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | x | ||
Pyrazolam | 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Pyrithyldione | 3,3-diethyl-1H-pyridine-2,4-dione | x | 4) | ||
Pyrovalerone | 4-methyl-β-ketone-prolintane Centroton | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | P IV | ||
Racemethorphan | (1RS,9RS,10RS)-4-methoxy-17-methyl-17azatetracyclo[7.5.3.0¹,¹⁰.0²,⁰]heptadeca-2,4,6-triene | N I | |||
Racemoramide | (3RS)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin1-ylbutan-1-one | N I | |||
Racemorphan | 17-methylmorphinan-3-ol | N I | |||
RCS-4 | SR-19 OBT-199 BTM-4 E-4 | (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | x | ||
RCS-4 4-hydroxyphenyl analogue | (4-hydroxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | x | |||
RCS-4 C4 homologue | (1-butyl-1H-indol-3-yl)(4-methoxyphenyl)methanone | x | |||
RCS-4 meta Isomer | RCS-4 3-methoxy Isomer | (3-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | x | ||
RCS-4 ortho Isomer | RCS-4 2-methoxy Isomer | (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | x | ||
Remifentanil | methyl 1-(3-methoxy-3-oxopropyl)-4-(Npropanoylanilino)piperidine-4-carboxylate | N I | |||
Rolicyclidine | PCPy PHP | 1-(1-phenylcyclohexyl)pyrrolidine | P I | x | |
Salvia divinorum | x | ||||
Salvinorin A | methyl 9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene7-carboxylate | x | |||
SDB-001 | N-(1-adamantyl)-1-pentyl-1H-indol-3-carboxamide | x | |||
SDB-006 | N-benzyl-1-pentyl-1H-indol-3-carboxamide | x | |||
Secbutabarbital | Secbutobarbitone Butabarbital Butabarbitone | 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione | P IV | ||
Secobarbital | Quinalbarbitone Secobarbitone Secobarbital sodium | 5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | P II | x | |
Senecioylfentanyl | β'-methyl Crotonyl fentanyl, 3,3-Dimethylacrylfentanyl | 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | x | ||
SL-164 | 5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4(3H)-one | x | |||
STS-135 | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
Sufentanil | N-[4-(methoxymethyl)-1-(2-thien-2-ylethyl)piperidin-4-yl]-Nphenylpropanamide | N I | |||
Tapentadol | 3-[1-(dimethylamino)-2-methylpentan-3-yl]phenol | x | 4) | ||
Temazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one | P IV | |||
Tenamphetamine | 3,4-methylenedioxyamphetamine MDA | 1-(1,3-benzodioxol-5-yl)propan-2-amine | P I | x | |
Tenocyclidine | TCP | 1-(1-(thien-2-yl)cyclohexyl)piperidine | P I | x | |
Tetrahydrocannabinol | THC (−)-trans-Δ9-tetrahydrocannabinol og öll isomer þess og afleiður, þ.m.t. tetrahydrocannabinolsýra | 6,6,9-trimethyl-3-pentyl-6a,7,8,10atetrahydrobenzo[c]chromen-1-ol | P I | x | 4) |
Tetrahydrofuranylfentanyl | tetrahydrofuranfentanyl, THF-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide | N I | ||
Tetramethylcyclopropylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyclopropane-1-carboxamide | x | |||
Tetrazepam | 7-chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4benzodiazepin-2-one | P IV | |||
Thebacon | Dihydrocodeinone enol acetate | 6,7-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6yl acetate | N I | ||
Thebaine | Paramorphine Codeine methyl enol ether | 6,7,8,14-tetradehydro-4,5-epoxy- 3,6-dimethoxy-17-methylmorphinan | N I | ||
Thiafentanil | methyl-4-[phenyl(methoxyacetyl)amino]-1-[2-(2-thienyl)ethyl]piperidin-4-carboxylate | x | |||
THJ-2201 | (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone | x | |||
Thiofentanyl | N-phenyl-N-[1-(2-(thien-2-yl)ethyl)piperidin-4yl]propanamide | N I+IV | |||
Thiopental | 5-ethyl-5-(pentan-2-yl)-2-sulfanylidene-1,3-diazinane-4,6dione | x | 4) | ||
TH-PHP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)hexan-1-one | x | |||
TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one | x | |||
Tiletamine | 2-(ethylamino)-2-(thiophen-2-yl)cyclohexan-1-one | x | |||
Tilidine | Tilidate | ethyl 2-dimethylamino-1-phenylcyclohex-3-ene-1carboxylate | N I | ||
TMA | 3,4,5-trimethoxyamphetamine 3,4,5-trimethoxyphenylisopropylamine | 1-(3,4,5-trimethoxyphenyl)propan-2-amine | P I | x | |
TMA-2 | 2,4,5-trimethoxyamphetamine 2,4,5-trimethoxyphenylisopropylamine | 1-(2,4,5-trimethoxyphenyl)propan-2-amine | x | ||
TMA-6 | 2,4,6-trimethoxyamphetamine 2,4,6-trimethoxyphenylisopropylamine | 1-(2,4,6-trimethoxyphenyl)propan-2-amine | x | ||
Tramadol | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan1-ol | x | 4) | ||
Triazolam | Chlorotriazolam | 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepine | P IV | ||
Trifluoromethylphenylpiperazine | TFMPP | 1-[3-(trifluoromethyl)phenyl]piperazine | x | ||
Trimeperidine | 1,2,5-trimethyl-4-phenylpiperidin-4-yl propionate | N I | |||
Tybamate | [2-(carbamoyloxymethyl)-2-methylpentyl]N-butylcarbamate | x | |||
U-47700 | 3,4-dichlor-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide | N I | |||
U-49900 | N-[2-(diethylamino)cyclohexyl]-3,4-dichloro-N-methylbenzamide | x | |||
UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | PII | |||
Valerylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]pentanamid | NI | x | ||
Vinbarbital | Vinbarbitone | 5-ethyl-5-[(E)-pent-2-en-2-yl]-1,3-diazinane-2,4,6-trione | x | 4) | |
Vinylbital | Butylvinal Vinylbitone | 5-ethenyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione | P IV | x | |
W-15 | 4-chloro-N-(1-(2-phenylethyl)-piperidin-2-ylidene)benzenesulfonamide | x | |||
W-18 | 4-chloro-N-(1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene)benzenesulfonamide | x | |||
WIN 55,212-2 | [2,3-Dihydro-5-methyl- 3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl] (1-napthalenylmethanone) | x | |||
Zapizolam | 8-chloro-6-(2-chlorophenyl)-4H-pyrido[2,3-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Zipeprol | 1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1phenylpropan-2-ol | P II | x | ||
Zolpidem | N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2a]pyridin-3-yl]acetamide | P IV | |||
zópíklón | Zopiklon | x | 4) | ||
α-D2PV | 1,2-diphenyl-2-(1-pyrrolidinyl)-ethanone | x | |||
α-diethylmethylaminopentiophenone | 1-fenyl-2-(1-metyletylamino)pentan-1-on | x | |||
α-Dimethylaminopentiophenone | x | ||||
α-EPP | α-ethylaminopentiophenone | x | |||
α-methylfentanyl | N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4yl]propanamide | N I+IV | |||
α-methylthiofentanyl | N-phenyl-N-[1-(1-thien-2-ylpropan-2-yl)piperidin-4-yl] propanamide | N I+IV | |||
α-methyltryptamine | AMT Indopan | 1-(1H-indol-3-yl)propan-2-amine | x | ||
α-PCYP | 2-cyclohexyl-1-phenyl-2-(pyrrolidin-1-yl)ethan-1-one | x | |||
α-PEP | 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one | x | |||
α-PHP | 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one | x | |||
α-PHPP | α-pyrrolidinoheptophenone | x | |||
α-PNP | 1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one | x | |||
α-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | x | |||
α-pyrrolidinobutiophenone | α-PBP | 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one | x | ||
α-pyrrolidinopentiophenone | α-pyrrolidinovalerophenone α-PVP | 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
α-pyrrolidinopropiophenone | α-PPP | 1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | x | ||
α-TMT | α-N,N-trimetyltryptamin | x | |||
β-hydroxy-3-methylfentanyl | N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide | N I + IV | |||
β-hydroxyfentanyl | N-[1-(2-hydroxy-2-phenylethyl)piperidin-4-yl]-Nphenylpropanamide | N I+IV |
Undanþágur og athugasemdir.
1) Innflutnings-/útflutningsleyfi þarf ekki fyrir lyf sem innihalda minna en 100 mg í hverjum afmældum skammti eða minna en 2,5% efnisins.
2) Ekki þarf innflutnings-/útflutningsleyfi vegna taflna sem innihalda allt að 2,5 mg dífenoxýlats, ef þær innhalda einnig minnst 25 mcg af atrópínsúlfati í hverri töflu.
3) Ekki þarf innflutnings-/útflutningsleyfi sérstaklega vegna lyfja sem innihalda minna en 135 mg dextróprópoxýfen í hverri afmældri einingu eða 2,5% efnisins í óskömmtuðu lyfjaformi. Lyfið má hins vegar ekki innihalda nein önnur ávana- og fíkniefni merkt P I–IV í fylgiskjali I.
4) Undanþegin eru: Efni sem veitt hefur verið undanþága fyrir skv. 3. mgr. 2. gr. laga um ávana- og fíkniefni, nr. 65/1974, með síðari breytingum, lyf sem hafa markaðsleyfi Lyfjastofnunar skv. lyfjalögum, lyf sem heimiluð hafa verið skv. lyfjalögum og efni sem veitt hefur verið leyfi til að flytja inn eða út, framleiða og selja í heildsölu skv. 1. mgr. 6. gr. reglugerðar þessarar um ávana- og fíkniefni og önnur eftirlitsskyld efni, nr. 233/2001.
5) Eftirfarandi er einnig undanþegið innflutnings- og útflutningsleyfi:
- Vörur sem heimilt er að markaðssetja hér á landi skv. annarri löggjöf en innihalda efnið í snefilmagni.
- Efnið sjálft ef tilætluð not þess eru til iðnaðarframleiðslu og lokaafurðin sem framleidd er hefur ekki eða er ekki talin hafa geðvirk áhrif og hráefnið getur ekki eða er ekki endurheimt frá lokaafurðinni.
Skýringar
D I - II Efni listuð á fylgiskjölum I–II með alþjóðasamningi gegn ólöglegri verslun með ávana- og fíkniefni 1988 (Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988).
Efni | Annað nafn | D I - II | Hámark án innflutningsleyfis |
1-phenyl-2-propanone | Fenýlaseton, benzýlmetýlketón | D I | |
3,4-MDP-2-P methyl glycidate | D I | ||
3,4-MDP-2-P methyl glycidic acid | D I | ||
3,4-methylenedioxyphenyl-2propanone | D I | ||
4-Anilino-N-phenethylpiperidine | ANPP | D I | |
Acetic anhydride | Ediksýruanhýdríð | D I | 100 l |
Acetone | Asetón | D II | |
alpha-Phenylacetoacetamide | APAA | D I | |
alpha-Phenylacetoacetonitrile | APAAN | D I | |
Anthranilic acid | Antranílsýra | D II | 1 kg |
Ephedrine | Efedrín | D I | |
Ergometrine | Ergometrín, Ergónóvín | D I | |
Ergotamine | Ergotamín | D I | |
Ethyl ether | Etýleter, eter, díetýleter | D II | |
Hydrochloric acid | Saltsýra, múríatínsýra | D II | |
Isosafrole | Ísósafról | D I | |
Lysergic acid | Lýsergsýra | D I | |
Methyl ethyl ketone | 2-bútanón, MEK | D II | |
N-acetylanthranilic acid | N-asetylantranílsýra | D I | |
Norephedrine | D I | ||
N-Phenethyl-4-piperidone | NPP | D I | |
Phenylacetic acid | Fenýlediksýra | D I | 1 kg |
Piperidine | Piperidín, hexahydropyridin | D II | 0,5 kg |
Piperonal | Piperonal, helíótrópín | D I | |
Potassium permanganate | Kalíumpermanganat | D I | 100 kg |
Pseudoephedrine | Pseudóefedrín | D I | |
Safrole | Safról | D I | |
Sulphuric acid | Brennisteinssýra, vítríólolía | D II | |
Toluene | Tólúen, metýlbensen | D II |
Fyrirvari
Reglugerðir eru birtar í B-deild Stjórnartíðinda skv. 3. gr. laga um Stjórnartíðindi og Lögbirtingablað, nr. 15/2005, sbr. reglugerð um útgáfu Stjórnartíðinda nr. 958/2005.
Sé misræmi milli þess texta sem birtist hér í safninu og þess sem birtur er í útgáfu B-deildar Stjórnartíðinda skal sá síðarnefndi ráða.